Literature DB >> 22535767

PTTG-binding factor (PBF) is a novel regulator of the thyroid hormone transporter MCT8.

V E Smith1, M L Read, A S Turnell, N Sharma, G D Lewy, J C W Fong, R I Seed, P Kwan, G Ryan, H Mehanna, S Y Chan, V M Darras, K Boelaert, J A Franklyn, C J McCabe.   

Abstract

Within the basolateral membrane of thyroid follicular epithelial cells, two transporter proteins are central to thyroid hormone (TH) biosynthesis and secretion. The sodium iodide symporter (NIS) delivers iodide from the bloodstream into the thyroid, and after TH biosynthesis, monocarboxylate transporter 8 (MCT8) mediates TH secretion from the thyroid gland. Pituitary tumor-transforming gene-binding factor (PBF; PTTG1IP) is a protooncogene that is up-regulated in thyroid cancer and that binds NIS and modulates its subcellular localization and function. We now show that PBF binds MCT8 in vitro, eliciting a marked shift in MCT8 subcellular localization and resulting in a significant reduction in the amount of MCT8 at the plasma membrane as determined by cell surface biotinylation assays. Colocalization and interaction between PBF and Mct8 was also observed in vivo in a mouse model of thyroid-specific PBF overexpression driven by a bovine thyroglobulin (Tg) promoter (PBF-Tg). Thyroidal Mct8 mRNA and protein expression levels were similar to wild-type mice. Critically, however, PBF-Tg mice demonstrated significantly enhanced thyroidal TH accumulation and reduced TH secretion upon TSH stimulation. Importantly, Mct8-knockout mice share this phenotype. These data show that PBF binds and alters the subcellular localization of MCT8 in vitro, with PBF overexpression leading to an accumulation of TH within the thyroid in vivo. Overall, these studies identify PBF as the first protein to interact with the critical TH transporter MCT8 and modulate its function in vivo. Furthermore, alongside NIS repression, PBF may thus represent a new regulator of TH biosynthesis and secretion.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22535767     DOI: 10.1210/en.2011-2030

Source DB:  PubMed          Journal:  Endocrinology        ISSN: 0013-7227            Impact factor:   4.736


  9 in total

1.  An extended proteome map of the lysosomal membrane reveals novel potential transporters.

Authors:  Agnès Chapel; Sylvie Kieffer-Jaquinod; Corinne Sagné; Quentin Verdon; Corinne Ivaldi; Mourad Mellal; Jaqueline Thirion; Michel Jadot; Christophe Bruley; Jérôme Garin; Bruno Gasnier; Agnès Journet
Journal:  Mol Cell Proteomics       Date:  2013-02-24       Impact factor: 5.911

Review 2.  Thyroid hormone transporters--functions and clinical implications.

Authors:  Juan Bernal; Ana Guadaño-Ferraz; Beatriz Morte
Journal:  Nat Rev Endocrinol       Date:  2015-05-05       Impact factor: 43.330

3.  Mutations in MCT8 in patients with Allan-Herndon-Dudley-syndrome affecting its cellular distribution.

Authors:  Simone Kersseboom; Gert-Jan Kremers; Edith C H Friesema; W Edward Visser; Wim Klootwijk; Robin P Peeters; Theo J Visser
Journal:  Mol Endocrinol       Date:  2013-04-02

Review 4.  Inherited defects of thyroid hormone-cell-membrane transport: review of recent findings.

Authors:  Jiao Fu; Samuel Refetoff; Alexandra M Dumitrescu
Journal:  Curr Opin Endocrinol Diabetes Obes       Date:  2013-10       Impact factor: 3.243

5.  The PTTG1-binding factor (PBF/PTTG1IP) regulates p53 activity in thyroid cells.

Authors:  Martin L Read; Robert I Seed; Jim C W Fong; Bhavika Modasia; Gavin A Ryan; Rachel J Watkins; Teresa Gagliano; Vicki E Smith; Anna L Stratford; Perkin K Kwan; Neil Sharma; Olivia M Dixon; John C Watkinson; Kristien Boelaert; Jayne A Franklyn; Andrew S Turnell; Christopher J McCabe
Journal:  Endocrinology       Date:  2014-02-07       Impact factor: 4.736

6.  Pro-invasive Effect of Proto-oncogene PBF Is Modulated by an Interaction with Cortactin.

Authors:  Rachel J Watkins; Waraporn Imruetaicharoenchoke; Martin L Read; Neil Sharma; Vikki L Poole; Erica Gentilin; Sukhchain Bansal; Emy Bosseboeuf; Rachel Fletcher; Hannah R Nieto; Ujjal Mallick; Allan Hackshaw; Hisham Mehanna; Kristien Boelaert; Vicki E Smith; Christopher J McCabe
Journal:  J Clin Endocrinol Metab       Date:  2016-09-07       Impact factor: 5.958

7.  Dimerization of the Sodium/Iodide Symporter.

Authors:  Rebecca J Thompson; Alice Fletcher; Katie Brookes; Hannah Nieto; Mohammed M Alshahrani; Jonathan W Mueller; Nicholas H F Fine; David J Hodson; Kristien Boelaert; Martin L Read; Vicki E Smith; Christopher J McCabe
Journal:  Thyroid       Date:  2019-08-30       Impact factor: 6.568

8.  Manipulation of PBF/PTTG1IP phosphorylation status; a potential new therapeutic strategy for improving radioiodine uptake in thyroid and other tumors.

Authors:  V E Smith; N Sharma; R J Watkins; M L Read; G A Ryan; P P Kwan; A Martin; J C Watkinson; K Boelaert; J A Franklyn; C J McCabe
Journal:  J Clin Endocrinol Metab       Date:  2013-05-15       Impact factor: 5.958

9.  Functional consequences of the first reported mutations of the proto-oncogene PTTG1IP/PBF.

Authors:  W Imruetaicharoenchoke; A Fletcher; W Lu; R J Watkins; B Modasia; V L Poole; H R Nieto; R J Thompson; K Boelaert; M L Read; V E Smith; C J McCabe
Journal:  Endocr Relat Cancer       Date:  2017-07-04       Impact factor: 5.678

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.